# Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery

> **NCT05648370** · — · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Oligometastatic Disease

## Interventions

- **GENETIC:** ctDNA testing and whole exome sequencing

## Key facts

- **NCT ID:** NCT05648370
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05648370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05648370, "Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05648370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*